Advanced Solid Tumors Clinical Trials in Beijing, Beijing Municipality
34 recruitingBeijing, Beijing Municipality, China
Showing 1–20 of 34 trials
Recruiting
Phase 1
A Study of BG-C477 in Participants With Advanced Solid Tumors
Advanced Solid Tumors
BeOne Medicines310 enrolled32 locationsNCT06596473
Recruiting
Phase 1Phase 2
Study of XNW28012 in Subjects With Advanced Solid Tumors Who Failed Standard Treatments
Ovarian CancerPancreatic CarcinomaAdvanced Solid Tumors+1 more
Evopoint Biosciences Inc.350 enrolled24 locationsNCT06799637
Recruiting
Phase 2
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Advanced Solid TumorsHER2 Mutation
Bayer111 enrolled54 locationsNCT06760819
Recruiting
Phase 1Phase 2
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
Metastatic Solid TumorsLocally Advanced Solid Tumors
Turning Point Therapeutics, Inc.500 enrolled165 locationsNCT03093116
Recruiting
Phase 1
A Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HRS-3802 Monotherapy in Patients With Malignant Solid Tumors
Advanced Solid Tumors
Shandong Suncadia Medicine Co., Ltd.100 enrolled6 locationsNCT06770569
Recruiting
Phase 1Phase 2
A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002)
Advanced Solid TumorsMalignant Neoplasm
Merck Sharp & Dohme LLC270 enrolled42 locationsNCT06818643
Recruiting
Phase 1Phase 2
An Open-label, First-in-Human, Dose-Escalation and Dose-Expansion Phase I/II Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SPR1020 in Patients With Advanced Solid Tumors
Advanced Solid TumorsPARP Inhibitor
Shanghai SciBrunch Therapeutics Co., Ltd.210 enrolled2 locationsNCT07359066
Recruiting
Phase 1
A Phase I Study to Evaluate the Safety,Tolerability, Pharmacokinetics, and Efficacy of YL211 in Patients With Advanced Solid Tumors
Advanced Solid Tumors
MediLink Therapeutics (Suzhou) Co., Ltd.155 enrolled21 locationsNCT06384352
Recruiting
Phase 1Phase 2
A Study of GFH375 Combined With Cetuximab or Chemotherapy in Participants With Solid Tumors Harboring KRAS G12D Mutation
Advanced Solid Tumors CancerPDACCRC (Colorectal Cancer)
Genfleet Therapeutics (Shanghai) Inc.126 enrolled4 locationsNCT07259590
Recruiting
Phase 1
An Open-label, Multi-center, Dose-escalation and Cohort Expansion Phase I/IIa Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile and Efficacy of ACR246 in Patients With Advanced Solid Tumors
Advanced Solid Tumors
Hangzhou Adcoris Biopharmacy Co., Ltd77 enrolled6 locationsNCT06238401
Recruiting
Phase 1Phase 2
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
Advanced Solid Tumors
DualityBio Inc.862 enrolled107 locationsNCT05914116
Recruiting
Phase 1Phase 2
A Study of GFH375 in Patients With Advanced Solid Tumors With KRAS G12D Mutations
Advanced Solid TumorsKRAS G12D Mutations
Genfleet Therapeutics (Shanghai) Inc.407 enrolled20 locationsNCT06500676
Recruiting
Phase 1Phase 2
AMT-253 in Patients With Advanced Solid Tumours
Advanced Solid TumorsMalignant Melanoma
Multitude Therapeutics Inc.96 enrolled1 locationNCT06209580
Recruiting
Phase 1
Study of HRS-1167 as Monotherapy in Patients With Advanced Solid Tumors
Advanced Solid Tumors
Jiangsu HengRui Medicine Co., Ltd.153 enrolled20 locationsNCT05473624
Recruiting
Phase 1
A Phase 1 Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of YL201 in Advanced Solid Tumors
Advanced Solid Tumors
MediLink Therapeutics (Suzhou) Co., Ltd.162 enrolled30 locationsNCT06394414
Recruiting
Phase 1Phase 2
A Trial of SHR-A2102 With or Without Antitumor Therapy in Advanced Solid Tumors
Advanced Solid Tumors
Shanghai Hengrui Pharmaceutical Co., Ltd.80 enrolled1 locationNCT06417554
Recruiting
Phase 1
Phase 1 Trial of KH617
Advanced Solid Tumors
Sichuan Honghe Biotechnology Co., Ltd.45 enrolled1 locationNCT05667194
Recruiting
Phase 1Phase 2
A Trial of SHR-A1811 Combined With Other Antitumor Therapies in Advanced Solid Tumors.
HER2-expressing Advanced Solid Tumors
Jiangsu HengRui Medicine Co., Ltd.364 enrolled15 locationsNCT06015048
Recruiting
Phase 1
Study Evaluating ISM8207 in Participants With Advanced Solid Tumors and Relapsed/Refractory B-Cell Lymphoma
Advanced Solid TumorsRelapsed/Refractory B-cell Lymphoma
InSilico Medicine Hong Kong Limited60 enrolled2 locationsNCT06445517
Recruiting
Phase 1
A Study of FDA022-BB05 in Subjects With Advanced Solid Malignant Tumors
Advanced Solid Tumors
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.107 enrolled1 locationNCT05564858